These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31185081)

  • 1. Reduced Mortality of Staphylococcus aureus Bacteremia in a Retrospective Cohort Study of 2139 Patients: 2007-2015.
    Austin ED; Sullivan SS; Macesic N; Mehta M; Miko BA; Nematollahi S; Shi Q; Lowy FD; Uhlemann AC
    Clin Infect Dis; 2020 Apr; 70(8):1666-1674. PubMed ID: 31185081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Length of stay, hospitalisation costs and in-hospital mortality of methicillin-susceptible and methicillin-resistant Staphylococcus aureus bacteremia in Japan.
    Tsuzuki S; Yu J; Matsunaga N; Ohmagari N
    Public Health; 2021 Sep; 198():292-296. PubMed ID: 34507134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spa type distribution in MRSA and MSSA bacteremias and association of spa clonal complexes with the clinical characteristics of bacteremia.
    Jokinen E; Lindholm L; Huttunen R; Huhtala H; Vuento R; Vuopio J; Syrjänen J
    Eur J Clin Microbiol Infect Dis; 2018 May; 37(5):937-943. PubMed ID: 29428976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Outcomes among Adult Patients with Nosocomial Bacteremia Caused by Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus: A Retrospective Cohort Study.
    Wang JT; Hsu LY; Lauderdale TL; Fan WC; Wang FD
    PLoS One; 2015; 10(12):e0144710. PubMed ID: 26690351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections.
    Kopp BJ; Nix DE; Armstrong EP
    Ann Pharmacother; 2004 Sep; 38(9):1377-82. PubMed ID: 15266044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of an assay that enables rapid determination of Staphylococcus species and their drug susceptibility on the treatment of patients with positive blood culture results.
    Parta M; Goebel M; Thomas J; Matloobi M; Stager C; Musher DM
    Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1043-8. PubMed ID: 20731594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How do the epidemiology of paediatric methicillin-resistant Staphylococcus aureus and methicillin-susceptible Staphylococcus aureus bacteraemia differ?
    Abernethy J; Sharland M; Johnson AP; Hope R
    J Med Microbiol; 2017 Jun; 66(6):737-743. PubMed ID: 28598316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methicillin-resistant and susceptible Staphylococcus aureus bacteremia and meningitis in preterm infants.
    Shane AL; Hansen NI; Stoll BJ; Bell EF; Sánchez PJ; Shankaran S; Laptook AR; Das A; Walsh MC; Hale EC; Newman NS; Schrag SJ; Higgins RD;
    Pediatrics; 2012 Apr; 129(4):e914-22. PubMed ID: 22412036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of long-term outcomes after meticillin-resistant and meticillin-sensitive Staphylococcus aureus bacteraemia: an observational cohort study.
    Yaw LK; Robinson JO; Ho KM
    Lancet Infect Dis; 2014 Oct; 14(10):967-75. PubMed ID: 25185461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and clinical characteristics of Staphylococcus aureus bloodstream infections in a tertiary-care center in Mexico City: 2003-2007.
    Ponce-de-León A; Camacho-Ortiz A; Macías AE; Landín-Larios C; Villanueva-Walbey C; Trinidad-Guerrero D; López-Jácome E; Galindo-Fraga A; Bobadilla-del-Valle M; Sifuentes-Osornio J
    Rev Invest Clin; 2010; 62(6):553-9. PubMed ID: 21416781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections - United States.
    Kourtis AP; Hatfield K; Baggs J; Mu Y; See I; Epson E; Nadle J; Kainer MA; Dumyati G; Petit S; Ray SM; ; Ham D; Capers C; Ewing H; Coffin N; McDonald LC; Jernigan J; Cardo D
    MMWR Morb Mortal Wkly Rep; 2019 Mar; 68(9):214-219. PubMed ID: 30845118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus.
    Wang JL; Chen SY; Wang JT; Wu GH; Chiang WC; Hsueh PR; Chen YC; Chang SC
    Clin Infect Dis; 2008 Mar; 46(6):799-806. PubMed ID: 18266610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and outcomes of community-associated methicillin-resistant Staphylococcus aureus infection.
    Davis SL; Perri MB; Donabedian SM; Manierski C; Singh A; Vager D; Haque NZ; Speirs K; Muder RR; Robinson-Dunn B; Hayden MK; Zervos MJ
    J Clin Microbiol; 2007 Jun; 45(6):1705-11. PubMed ID: 17392441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus.
    Harbarth S; Rutschmann O; Sudre P; Pittet D
    Arch Intern Med; 1998 Jan; 158(2):182-9. PubMed ID: 9448557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vancomycin MICs and risk of complicated bacteremia by glycopeptide-susceptible Staphylococcus aureus.
    Falcón R; Mateo E; Oltra R; Giménez E; Albert E; Torres I; Navarro D
    Eur J Clin Microbiol Infect Dis; 2019 May; 38(5):903-912. PubMed ID: 30729396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of bloodstream infections caused by methicillin-resistant Staphylococcus aureus at a tertiary care hospital in New York.
    Yasmin M; El Hage H; Obeid R; El Haddad H; Zaarour M; Khalil A
    Am J Infect Control; 2016 Jan; 44(1):41-6. PubMed ID: 26412481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006.
    Laupland KB; Ross T; Gregson DB
    J Infect Dis; 2008 Aug; 198(3):336-43. PubMed ID: 18522502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic susceptibility and genomic variations in Staphylococcus aureus associated with Skin and Soft Tissue Infection (SSTI) disease groups.
    Changchien CH; Chen SW; Chen YY; Chu C
    BMC Infect Dis; 2016 Jun; 16():276. PubMed ID: 27287530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excess costs and utilization associated with methicillin resistance for patients with Staphylococcus aureus infection.
    Filice GA; Nyman JA; Lexau C; Lees CH; Bockstedt LA; Como-Sabetti K; Lesher LJ; Lynfield R
    Infect Control Hosp Epidemiol; 2010 Apr; 31(4):365-73. PubMed ID: 20184420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the efficacy of nafcillin and glycopeptides as definitive therapy for patients with methicillin-susceptible Staphylococcus aureus bacteremia: a retrospective cohort study.
    Oh DH; Kim JJ; Kim J; Seong H; Lee SJ; Kim YC; Kim EJ; Jung IY; Jeong WY; Jeong SJ; Ku NS; Han SH; Choi JY; Song YG; Kim JM
    BMC Infect Dis; 2018 Jan; 18(1):60. PubMed ID: 29378565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.